Jose Pérez-García, Gabriele Antonarelli, Maria Gion, Antonio Llombart-Cussac, Javier Cortés
{"title":"Moving toward response-adapted trials in oncology","authors":"Jose Pérez-García, Gabriele Antonarelli, Maria Gion, Antonio Llombart-Cussac, Javier Cortés","doi":"10.1038/s41591-024-03346-3","DOIUrl":null,"url":null,"abstract":"The I-SPY clinical trial platform was designed to accelerate clinical development of neoadjuvant treatments for early-stage breast cancer. Although it is not without limitations, it provides a model for future response-adapted clinical trials.","PeriodicalId":58,"journal":{"name":"The Journal of Physical Chemistry ","volume":"69 1","pages":""},"PeriodicalIF":2.7810,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Physical Chemistry ","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-024-03346-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The I-SPY clinical trial platform was designed to accelerate clinical development of neoadjuvant treatments for early-stage breast cancer. Although it is not without limitations, it provides a model for future response-adapted clinical trials.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
